FHFeng Huo

Feng Huo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Feng Huo has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Metachronous Hilar Cholangiocarcinoma Presenting as Recurrent Liver Abscesses After Pancreaticoduodenectomy

    by Tengfei Qi, Zhengyong Xie, Zicheng Wang, Jianxiong Chen, Zhiping Huang, Shutong Lu, Rendong Liu, Feng Huo, Ru Ji

  • JoVE Video Dataset

    by Jordi Vengohechea, Soraya Rodríguez, Alicia Izquierdo, Javier Muñoz, Paula P. Burgos, Joaquim Albiol, Carlota Largo, Mingju Liang, Fen Huo, Amelia J. Hessheimer, et al.

    Ex situ normothermic machine perfusion (NMP) of the liver has emerged as a dynamic preservation strategy, enabling the maintenance of metabolic activity and assessment of grafts prior to transplantation. Prolonged perfusions, however, are limited by the accumulation of metabolic waste, electrolyte imbalances, and inflammatory mediators that can compromise graft function. Continuous renal replacement therapies (CRRT), especially continuous venovenous hemodiafiltration (CVVHDF), offer a potential means to support solute clearance and homeostatic regulation during extended perfusion periods. In this protocol, we describe a reproducible and safe method for integrating CVVHDF into an ex situ liver NMP system by connecting the filtration circuit independently from the main organ perfusion circuit. This configuration supports hemodynamic stability, helps prevent excessive intravascular pressures, and may reduce the risk of tissue edema. The physical connection, priming, and monitoring of the CRRT circuit are explained in detail, along with instructions on how to utilize a Hoffman clamp to simulate physiological venous pressure. When compared to direct in-line circuit integration, representative results suggest that the out-of-circuit approach is associated with reduced graft edema, while maintaining stable circuit pressure and solute clearance. This approach can be easily integrated into other similar perfusion devices in order to improve solute handling while maintaining stable perfusion dynamics.

  • Integrating Continuous Renal Replacement Therapy into Ex-situ Normothermic Liver Machine Perfusion

    by Jordi Vengohechea, Soraya Rodríguez, Alicia Izquierdo, Javier Muñoz, Paula P. Burgos, Joaquim Albiol, Carlota Largo, Mingju Liang, Fen Huo, Amelia J. Hessheimer, et al.

    Ex situ normothermic machine perfusion (NMP) of the liver has emerged as a dynamic preservation strategy, enabling the maintenance of metabolic activity and assessment of grafts prior to transplantation. Prolonged perfusions, however, are limited by the accumulation of metabolic waste, electrolyte imbalances, and inflammatory mediators that can compromise graft function. Continuous renal replacement therapies (CRRT), especially continuous venovenous hemodiafiltration (CVVHDF), offer a potential means to support solute clearance and homeostatic regulation during extended perfusion periods. In this protocol, we describe a reproducible and safe method for integrating CVVHDF into an ex situ liver NMP system by connecting the filtration circuit independently from the main organ perfusion circuit. This configuration supports hemodynamic stability, helps prevent excessive intravascular pressures, and may reduce the risk of tissue edema. The physical connection, priming, and monitoring of the CRRT circuit are explained in detail, along with instructions on how to utilize a Hoffman clamp to simulate physiological venous pressure. When compared to direct in-line circuit integration, representative results suggest that the out-of-circuit approach is associated with reduced graft edema, while maintaining stable circuit pressure and solute clearance. This approach can be easily integrated into other similar perfusion devices in order to improve solute handling while maintaining stable perfusion dynamics.


  • Open Access

    Survival outcomes of patients after liver transplantation for patients with hepatocellular carcinoma exceeding the Hangzhou criteria

    by Zhi-Ping Huang, Shu-Tong Lu, Jin Du, Ren-Dong Liu, Qing Ouyang, Bao Zhang, Meng-Chao Wang, Diamantis I. Tsilimigras, Hani M. Wadei, Yu-Jian Zheng, et al.

    Background: Patient selection is one of the key factors influencing prognosis after liver transplantation (LT), and a number of selection criteria have been proposed and broadly applied. The benefit of LT is debatable when patients exceed these criteria in light of liver worldwide donor shortage. This study aims to identify key prognostic indicators predicting patients undergoing LT beyond Hanzhou criteria, to guide LT candidate selection. Methods: The clinical data and pathological findings of patients who underwent LT in the Liver Transplantation Center of General Hospital of Southern Theatre Command from September 2003 to August 2017 were collected for retrospective analysis, only patients exceeding the Hangzhou criteria were enrolled. Patients were followed up until December 1, 2023; disease-free survival (DFS) and overall survival (OS) was analyzed; and predictive models of DFS and OS were constructed and validated. Results: A total of 161 patients were included in the analysis. A tumor diameter ≥6 cm [hazard ratio (HR) =2.01; P=0.01], alpha fetoprotein (AFP) levels >1,000 ng/mL (HR =2.68; P2,000 mL (HR =1.75; P=0.01), and female donor gender (HR =3.71; P=0.004) were independent risk factors for lower DFS, while a tumor diameter ≥6 cm (HR =2.05; P=0.001), AFP level >1,000 ng/mL (HR =1.54; P=0.04), and female donor gender (HR =4.45; PConclusions: For patients exceeding the Hangzhou criteria, those with an AFP level ≤1,000 ng/mL can still achieve acceptable long-term prognosis after LT. Administration of metformin has a strong positive association with longer recurrence-free survival. The patient criteria for selection for LT can be tentatively expanded.

  • Six-hour local 4 °C dual hypothermic oxygenated machine perfusion improves the preservation of porcine liver after cardiac death using an ex vivo reperfusion model

    by Xiao-Yu Tan, Wei-Jian Kuang, Fei-Wen Deng, Zhi-Ping Huang, Qing Ouyang, Xiao-Tao Huang, Wai I Ho, Ming-Ju Liang, Feng Huo, Huan-Wei Chen


  • Preservation of Porcine Donation after Circulatory Death (DCD) Liver by Perfusion and Orthotopic Liver Transplantation

    by Qing OuYang, Xiaoyu Tan, Liyue Sun, Weijian Kuang, Xiran He, Mingju Liang, Yujian Zheng, Ru Ji, Mengchao Wang, Zhiping Huang, et al.

    Conventional static cold storage (SCS) exacerbates ischemic injury in the DCD liver, leading to severe complications for transplant recipients. To address this issue, clinical application of MP technology for donor liver preservation is underway. Simultaneously, efforts are focused on the development of various MP instruments, validated through relevant animal model experiments. Effective large animal trials play a pivotal role in clinical applications. However, challenges persist in the ex vivo preservation of DCD livers and the transplantation procedure in pigs. These hurdles encompass addressing the prolonged preservation of donor livers, conducting viability tests, alleviating ischemic injuries, and shortening the anhepatic phase. The use of a variable temperature-controlled MP device facilitates the prolonged preservation of DCD livers through sequential Dual Hypothermic Oxygenated Machine Perfusion (DHOPE) and Normothermic Machine Perfusion (NMP) modes. This protocol enhances the porcine OLTx model by improving the quality of DCD livers, optimizing the anastomosis technique, and reducing the duration of the anhepatic phase.

  • Open Access

    Evaluation of the ex vivo liver viability using a nuclear magnetic resonance relaxation time-based assay in a porcine machine perfusion model

    by Qing OuYang, Guohai Liang, Xiaoyu Tan, Xiran He, Lin Zhang, Weijian Kuang, Jianxiong Chen, Shaoping Wang, Mingju Liang, Feng Huo

    There is a dearth of effective parameters for selecting potentially transplantable liver grafts from expanded-criteria donors. In this study, we used a nuclear magnetic resonance (NMR) relaxation analyzer-based assay to assess the viability of ex vivo livers obtained via porcine donation after circulatory death (DCD). Ex situ normothermic machine perfusion (NMP) was utilized as a platform for viability test of porcine DCD donor livers. A liver-targeted contrast agent, gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA), was injected into the perfusate during NMP, and the dynamic biliary excretion of the Gd-EOB-DTPA was monitored by measuring the longitudinal relaxation time (T1). The longitudinal relaxation rate (R1) of the bile was served as a parameter. The delay of increase in biliary R1 during early stage of NMP indicated the impaired function of liver grafts in both warm and cold ischemia injury, which was correlated with the change of alanine aminotransferase. The preservative superiority in cold ischemia of dual hypothermic oxygenated machine perfusion could also be verified by assessing biliary R1 and other biochemical parameters. This study allows for the dynamic assessment of the viability of porcine DCD donor livers by combined usage of ex situ NMP and NMR relaxation time based assay, which lays a foundation for further clinical application.